Centre for Neuroscience and Trauma, Blizard Institute, Queen Mary University of London, Barts and the London School of Medicine and Dentistry, London, UK.
BMJ Open. 2013 Mar 11;3(3):e002508. doi: 10.1136/bmjopen-2012-002508.
Suboptimal bone health is increasingly recognised as an important cause of morbidity. Multiple sclerosis (MS) has been consistently associated with an increased risk of osteoporosis and fracture. Various fracture risk screening tools have been developed, two of which are in routine use and a further one is MS-specific. We set out to compare the results obtained by these in the MS clinic population.
This was a service development study. The 10-year risk estimates of any fracture and hip fracture generated by each of the algorithms were compared.
The MS clinic at the Royal London Hospital.
88 patients with a confirmed diagnosis of MS.
Mean 10-year overall fracture risk and hip fracture risk were calculated using each of the three fracture risk calculators. The number of interventions that would be required as a result of using each of these tools was also compared.
Mean 10-year fracture risk was 4.7%, 2.3% and 7.6% using FRAX, QFracture and the MS-specific calculator, respectively (p<0.0001 for difference). The agreement between risk scoring tools was poor at all levels of fracture risk.
The agreement between these three fracture risk scoring tools is poor in the MS population. Further work is required to develop and validate an accurate fracture risk scoring system for use in MS.
This service development study was approved by the Clinical Effectiveness Department at Barts Health NHS Trust (project registration number 156/12).
越来越多的人认识到骨骼健康不佳是发病率增加的一个重要原因。多发性硬化症(MS)一直与骨质疏松症和骨折风险增加有关。已经开发出多种骨折风险筛查工具,其中两种在常规使用,还有一种是 MS 专用的。我们旨在比较这些工具在 MS 诊所人群中的结果。
这是一项服务开发研究。比较了这些算法得出的任何骨折和髋部骨折的 10 年风险估计值。
伦敦皇家医院的 MS 诊所。
88 名确诊为 MS 的患者。
使用三种骨折风险计算器中的每一种计算得出的平均 10 年总体骨折风险和髋部骨折风险。还比较了使用这些工具中的每一种所需的干预措施数量。
使用 FRAX、QFracture 和 MS 专用计算器得出的平均 10 年骨折风险分别为 4.7%、2.3%和 7.6%(差异具有统计学意义,p<0.0001)。在所有骨折风险水平上,风险评分工具之间的一致性都很差。
在 MS 人群中,这三种骨折风险评分工具之间的一致性很差。需要进一步开发和验证一种准确的 MS 骨折风险评分系统。
这项服务开发研究得到了 Barts Health NHS Trust 临床效果部的批准(项目注册号 156/12)。